Free tool
FAERS Monitor: Vancomycin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 213895 or its brand name (Vancomycin, Vancomycin). Reports on generic versions are filed under their own applications.
Reports
65,564
Serious
60,431
92% of reports
Hospitalization
34,824
Death reported
12,910
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective7,429
- acute kidney injury4,911
- off label use4,760
- pyrexia4,067
- drug reaction with eosinophilia and systemic symptoms2,707
- renal failure2,435
- diarrhoea2,373
- sepsis2,360
- condition aggravated2,220
- pneumonia2,210
- rash2,186
- hypotension2,167
- dyspnoea1,846
- septic shock1,819
- nausea1,770
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 859 |
| 2005 | 914 |
| 2006 | 1,010 |
| 2007 | 870 |
| 2008 | 1,115 |
| 2009 | 1,029 |
| 2010 | 1,332 |
| 2011 | 1,905 |
| 2012 | 1,897 |
| 2013 | 1,859 |
| 2014 | 1,939 |
| 2015 | 2,457 |
| 2016 | 2,759 |
| 2017 | 3,352 |
| 2018 | 4,563 |
| 2019 | 4,401 |
| 2020 | 5,226 |
| 2021 | 5,112 |
| 2022 | 4,843 |
| 2023 | 4,912 |
| 2024 | 5,153 |
| 2025 | 4,995 |
| 2026 | 3,057 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,988,595 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug reaction with eosinophilia and systemic symptomsSignal | 2,707 | 37.6 | 36.2 | 86,367 |
| septic shockSignal | 1,819 | 14.0 | 13.3 | 20,992 |
| acute kidney injurySignal | 4,911 | 10.6 | 10.3 | 41,635 |
| sepsisSignal | 2,360 | 6.9 | 6.6 | 11,739 |
| renal failureSignal | 2,435 | 6.0 | 5.7 | 9,956 |
| pyrexiaSignal | 4,067 | 3.8 | 3.7 | 8,442 |
| hypotensionSignal | 2,167 | 3.5 | 3.4 | 3,847 |
| condition aggravatedSignal | 2,220 | 2.4 | 2.3 | 1,737 |
| pneumoniaSignal | 2,210 | 2.2 | 2.1 | 1,454 |
| drug ineffective | 7,429 | 1.8 | 1.8 | 2,872 |
| off label use | 4,760 | 1.7 | 1.7 | 1,580 |
| rash | 2,186 | 1.6 | 1.5 | 515 |
| diarrhoea | 2,373 | 1.2 | 1.1 | 67 |
| dyspnoea | 1,846 | 1.0 | 1.0 | 4 |
| nausea | 1,770 | 0.7 | 0.7 | 205 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.